EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Global ALPL gene variant classification project: Dedicated to deciphering variants

Mariam R Farman, Catherine Rehder, Theodora Malli, Cheryl Rockman-Greenberg, Kathryn Dahir, Gabriel Ángel Martos-Moreno, Agnès Linglart, Keiichi Ozono, Lothar Seefried, Guillermo Del Angel, Gerald Webersinke, Francesca Barbazza und 9 weitere

Bone · 2024-01 · 178 · 116947

DOI: 10.1016/j.bone.2023.116947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2024-01. Verfasst von Mariam R Farman und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Linz, Austria. Hauptthemen laut MEDLINE: Alkaline Phosphatase, Hypophosphatasia. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexion Pharmaceuticals Inc, Duke University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypophosphatasia (HPP) is an inherited multisystem disorder predominantly affecting the mineralization of bones and teeth. HPP is caused by pathogenic variants in ALPL, which encodes tissue non-specific alkaline phosphatase (TNSALP). Variants of uncertain significance (VUS) cause diagnostic delay and uncertainty amongst patients and health care providers. RESULTS: The ALPL gene variant database (https://alplmutationdatabase.jku.at/) is an open-access archive for interpretation of the clinical significance of variants reported in ALPL. The database contains coding and non-coding variants, including single nucleotide variants, insertions/deletions and structural variants affecting coding or non-coding sequences of ALPL. Each variant in the database is displayed with details explaining the corresponding pathogenicity, and all reported genotypes and phenotypes, including references. In 2021, the ALPL gene variant classification project was established to reclassify VUS and continuously assess and update genetic, phenotypic, and functional variant information in the database. For this purpose, the database provides a unique submission system for clinicians, geneticists, genetic counselors, and researchers to submit VUS within ALPL for classification. An international, multidisciplinary consortium of HPP experts has been established to reclassify the submitted VUS using a multi-step process adhering to the stringent ACMG/AMP variant classification guidelines. These steps include a clinical phenotype assessment, deep literature research including artificial intelligence technology, molecular genetic assessment, and in-vitro functional testing of variants in a co-transfection model to measure ALP residual activity. CONCLUSION: This classification project and the ALPL gene variant database will serve the global medical community, widen the genotypic and phenotypic HPP spectrum by reporting and characterizing new ALPL variants based on ACMG/AMP criteria and thus facilitate improved genetic counseling and medical decision-making for affected patients and families. The project may also serve as a gold standard framework for multidisciplinary collaboration for variant interpretation in other rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alkaline PhosphataseHypophosphatasiaHumansMutationArtificial IntelligenceDelayed Diagnosis

Stichwörter der Autor:innen

ACMGAlkaline phosphataseHypophosphatasiaReclassificationVitamin B6

Substanzen

Alkaline PhosphataseALPL protein, human

Autor:innen und Institutionen

  • Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Linz, Austria.
  • Duke University Medical Center, Department of Pathology, Durham, USA.
  • Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, Linz, Austria.
  • Department of Pediatrics and Child Health Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Canada.
  • Vanderbilt University Medical Center, Program for Metabolic Bone Disorders, Nashville, TN, USA.
  • Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Förderung

  • Alexion Pharmaceuticals Inc
  • Duke University

Zitieren

APA

Farman, M. R., Rehder, C., Malli, T., Rockman-Greenberg, C., Dahir, K., Martos-Moreno, G. Á., Linglart, A., Ozono, K., Seefried, L., Del Angel, G., Webersinke, G., Barbazza, F., John, L. K., Delana Mudiyanselage, S. M. A., Högler, F., Nading, E. B., Huggins, E., Rush, E. T., El-Gazzar, A., …, & Högler, W. (2024). The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone, 178, 116947. https://doi.org/10.1016/j.bone.2023.116947

Vancouver

Farman MR, Rehder C, Malli T, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, et al. The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 2024;178:116947. doi:10.1016/j.bone.2023.116947

BibTeX
@article{Farman2024,
  author = {Farman, Mariam R and Rehder, Catherine and Malli, Theodora and Rockman-Greenberg, Cheryl and Dahir, Kathryn and Martos-Moreno, Gabriel Ángel and Linglart, Agnès and Ozono, Keiichi and Seefried, Lothar and Del Angel, Guillermo and Webersinke, Gerald and Barbazza, Francesca and John, Lisa K and Delana Mudiyanselage, Sewmi M A and Högler, Florian and Nading, Erica Burner and Huggins, Erin and Rush, Eric T and El-Gazzar, Ahmed and Kishnani, Priya S and Högler, Wolfgang},
  title = {The Global ALPL gene variant classification project: Dedicated to deciphering variants},
  journal = {Bone},
  year = {2024},
  volume = {178},
  pages = {116947},
  doi = {10.1016/j.bone.2023.116947}
}
Kostenlos starten →